Close

Exelixis (EXEL) Announces Initiation of CS-3150 Phase 3 as Selective Mineralocorticoid Receptor Antagonist

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/16/2024

1. SPY
2. TSLA
3. JNJ
4. AMD
5. ITCI
6. GS
7. BAC
8. MS
9. BK
10. UNH


Go back to Exelixis (EXEL) Announces Initiation of CS-3150 Phase 3 as Selective Mineralocorticoid Receptor Antagonist
Exelixis, Inc. (NASDAQ: EXEL) Delayed: 22.82 +0.12 (0.53%)
Previous Close $22.70    52 Week High $17.00 
Open $22.60    52 Week Low $3.55 
Day High $23.08    P/E N/A 
Day Low $22.53    EPS $-1.33 
Volume 1,693,158